Ultragenyx Pharmaceutical Inc (RARE)
45.26
+1.58
(+3.62%)
USD |
NASDAQ |
Apr 23, 14:43
Ultragenyx Pharmaceutical Total Assets (Quarterly): 1.491B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.491B |
| September 30, 2023 | 1.238B |
| June 30, 2023 | 1.311B |
| March 31, 2023 | 1.383B |
| December 31, 2022 | 1.545B |
| September 30, 2022 | 1.618B |
| June 30, 2022 | 1.321B |
| March 31, 2022 | 1.384B |
| December 31, 2021 | 1.522B |
| September 30, 2021 | 1.485B |
| June 30, 2021 | 1.512B |
| March 31, 2021 | 1.598B |
| December 31, 2020 | 1.760B |
| September 30, 2020 | 1.268B |
| June 30, 2020 | 1.314B |
| March 31, 2020 | 1.233B |
| December 31, 2019 | 1.135B |
| September 30, 2019 | 879.94M |
| June 30, 2019 | 958.93M |
| March 31, 2019 | 1.008B |
| December 31, 2018 | 719.56M |
| September 30, 2018 | 765.14M |
| Date | Value |
|---|---|
| June 30, 2018 | 806.02M |
| March 31, 2018 | 817.35M |
| December 31, 2017 | 490.75M |
| September 30, 2017 | 435.05M |
| June 30, 2017 | 497.54M |
| March 31, 2017 | 545.82M |
| December 31, 2016 | 540.63M |
| September 30, 2016 | 515.17M |
| June 30, 2016 | 481.95M |
| March 31, 2016 | 524.18M |
| December 31, 2015 | 559.57M |
| September 30, 2015 | 602.13M |
| June 30, 2015 | 343.00M |
| March 31, 2015 | 355.84M |
| December 31, 2014 | 197.97M |
| September 30, 2014 | 210.93M |
| June 30, 2014 | 162.59M |
| March 31, 2014 | 172.71M |
| December 31, 2013 | 59.65M |
| September 30, 2013 | 68.59M |
| December 31, 2012 | 88.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
879.94M
Minimum
Sep 2019
1.760B
Maximum
Dec 2020
1.366B
Average
1.383B
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 621.52M |
| Madrigal Pharmaceuticals Inc | 640.55M |
| Sarepta Therapeutics Inc | 3.265B |
| FibroGen Inc | 423.53M |
| Rocket Pharmaceuticals Inc | 566.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.216B |
| Shareholders Equity (Quarterly) | 275.41M |
| Current Ratio | 2.611 |